Pharsight

Drugs that contain Milnacipran Hydrochloride

1. Savella patents expiration

Can you believe SAVELLA received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6602911 ALLERGAN Methods of treating fibromyalgia
Jan, 2023

(1 year, 1 month ago)

US7994220 ALLERGAN Milnacipran for the long-term treatment of fibromyalgia syndrome
Sep, 2029

(5 years from now)

Market Authorisation Date: 14 January, 2009

Treatment: Management of fibromyalgia (fm); Management of fibromyalgia

Dosage: TABLET;ORAL

How can I launch a generic of SAVELLA before it's drug patent expiration?
More Information on Dosage

SAVELLA family patents

Family Patents